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Abstract: 
Salmonella enteric serovar Typhi Ty2 is a human specific pathogen and an etiological agent for typhoid fever. Most of Salmonella 
serotypes produce glycogen which has a comparatively minor role in virulence and colonization, but has a more significant role in 
survival. Enzymes present in glycolytic pathway of bacteria help bacteria to survive by activating other factors inside host. 
Numerous pathogenic bacteria species intervene with the plasminogen system, and this plasminogen–enolase association may play 
a critical role in the virulence of S. Typhi by causing direct damage to the host cell extracellular matrix, possibly by enzymic 
degradation of extracellular matrix proteins or other protein constituents. In this study, molecular modelling of enolase of 
Salmonella has been accomplished in silico by comparative modelling; we have then analyzed Human alpha enolase which is a 
homodimer and serves on epithelial cells with our model. Both Structures were docked by D-tartronate semialdehyde phosphate 
(TSP) and 3-aminoenolpyruvate phosphate (AEP) enolase inhibitors. Our study shows that salmonella enolase and human enolase 
have different active sites in their structure. This will help in development of new ligands, more suitable for inhibiting bacterial 
survival inside host as vaccines for typhoid fever are not fully protective.  The study also confirmed that enolase Salmonella and 
Human Plasminogen suggested direct physical interaction between both of them as the activation loop of plasminogen residues 
showed conformational changes similar to the tissue type plasminogen activator. Various computational biology tools were used 
for our present study such as Modeller, Molegro Virtual Docker, Grommacs. 
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Background: 
Pathogenesis of S. Typhi is not completely understood. The 
treatment of typhoid fever is complicated by the emergence of 
drug resistance. Effectiveness of currently available vaccines is 
also limited. The major shortcomings of the live vaccine are the 
cost and requirement of multiple doses which do not enhance 
protection. Further, memory cells are not generated which also 
fails to induce intestinal secretory IgA response. 
Approximately 21 million cases are estimated, resulting in 
216,519 deaths in the year 2000. More than half of all 
Salmonella enterica serovar Typhi genes still remain 
unannotated. Enolase is a ubiquitous enzyme that catalyzes the 
reversible conversion of 2-phosphoglycerate (2-PGE) to 
phosphoenolpyruvate (PEP). In addition to its metabolic role, 
[1] enolase has been implicated for its contribution to several 
biological and pathophysiological processes by acting as a heat BIOINFORMATION 
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shock protein and in modulating gene transcription, as well as 
for its involvement in microbial diseases and autoimmunity 
gene. This implies that enolase is not a housekeeping gene 
since;  its expression varies according to the 
pathophysciologically metabolic or development condition of 
cell [2-5]. The presence of α-enolase on the surface of bacteria 
adds a new insight in the generation of antibodies against 
enolase, post infection. Numerous pathogenic bacterial species 
intervene with the plasminogen system and a hypothesis has 
emerged that bacteria use this system for migration across 
tissue barriers or for nutritional demands during infection. 
Cell-surface protein-mediated interactions are known to play a 
major role in disease-progression. In various pathogenic 
systems, including bacteria, fungi and protozoa, the invasive 
phenotype has been correlated with the ability of the organism 
to bind to laminin, an abundant extracellular matrix 
glycoprotein. For an in-silico validation of this hypothesis, a 3-
D model of salmonella enolase has been constructed, 
considering enolase-palsminogen interaction between 
salmonella and human plasminogen. Structure based 
comparative analyses of Salmonella enolase and Human alpha 
enolase was performed in which different active residues and 
different active pockets in both structures were found. Both 
molecules were docked with enolase inhibitors, TSP (D-
tartronate semialdehyde phosphate) and AEP (3-
aminoenolpyruvate phosphate) [6] i n  o r d e r  t o  i n h i b i t  
salmonella’s survival mechanism inside the host. This work 
will prove to be strategic for development of new inhibitors for 
Salmonella Tphi Ty2.  
 
Invasive bacteria have evolved virulence strategies to interact 
with host hemostatic factors such as plasminogen and 
fibrinogen for infection. Different bacterial species gain access 
to the human body through different sites, such as the skin, 
nasopharynx, lungs, gastrointestinal, or urogenital tract. 
Bacterial invasion is generally mediated by bacterial surface 
and secreted products that can negate host innate and acquired 
defense systems.[7] Several gram-positive and gram-negative 
invasive bacterial pathogens have been found to express a 
plasminogen receptor (PlgR) function. These bacteria 
immobilize plasminogen on their cell surfaces and enhance the 
tPA catalyzed plasminogen activation. The bacterial 
plasminogen receptor functions to generate proteolytic activity 
on the bacterial surface by utilizing a host-derived proteolytic 
system. [8]  Salmonella enterica have been identified as PlgRs 
Bacterial enzymes acting directly on mammalian extra cellular 
matrix (ECM) or activating on latent procollagenases. It is an 
established fact that plasmin degrades noncollagenous 
p r o t e i n s  o f  E C M ,  s u c h  a s  l a minin, and activates latent 
procollagenases. It has also been proposed that one function of 
bacterial PlgRs is to potentiate bacterial damage to and 
bacterial spread through tissue barriers, such as basement 
membranes. [9, 10]  In vitro tissue culture studies have 
identified some of the host cell responses that lead to 
Salmonella entry including actin rearrangement and 
polymerization at host cell membrane and accumulation of 
cytoskeleton protein at the site of bacterial entry [11]. Most 
Salmonella serotypes produce glycogen playing a 
comparatively minor role in virulence and colonization, but 
having a more significant role in survival. Enzymes present in 
glycolytic pathway of bacteria helps in survival by activating 
other factors which leads deeper into tissues away from 
immune response.  
 
Methodology: 
Protein Modeling & Structure analysis: 
Protein Sequence of Salmonella enolase was obtained from 
NCBI GeneBank (Accession number GI2938841). Molecular 
structures of Salmonella enolase were modeled by using 
restraint-based modeling implemented in the program 
Modeller9v8  [12]. Further, the structure was refined and 
energy minimized with the insertion of Mg++ at the active site 
of our modeled structure. Energy minimization and structure 
refinement was done by Grommacs and Chimera program 
respectively. The modeled structure and Human alpha enolase 
structure (3B97), a homodimer structure were analysed for 
differences in their binding sites, active residues and active 
pockets by Castp and Pocket finder server respectively. 
 
Protein-Protein Docking: 
To study, enolase-plasminogen interaction the crystal 
structures of plasminogen 1B2I and 1DDJ were studied. 
Protein-protein docking was conducted on Grommacs server 
and VEGAZZ Program. For better results both docked 
structures were analyzed for conformational changes. 
 
Protein Ligand Docking: 
Both Salmonella and Human enolase were docked with 
enolase inhibitors CID: 151938 “TSP”, CID: 3037152 “AEP” by 
proved enolase inhibitors using Molegro Virtual Docker. 
 
Discussions: 
The overall quality of our structure on the basis of the 
Ramachandran plot showed that 94.7% of residues were found 
in favored region (407 out of 432), 4% of residues in allowed 
regions (17 out of 432), while only 1.4% (6 out of 432) appeared 
in outlier regions. Human alpha enolase and salmonella 
enolase RSMD was found to be 2.36 by Superpose server. 
Enolase binds with 2-phosphoglycerate, where Gln167 and 
Lys396 are active residues, and are essential to hold and bind 
the divalent magnesium cation. This facilitates the rotation and 
neutralization of carboxyl group of PGA. Enolase catalyzes 11 
different chemical reactions commonly as initial metal assisted 
abstraction of carboxylate group. A different active-site pocket 
catalyzes variety of chemical reactions including racemization, 
cycloisomerization and elimination of either water or 
ammonia. For a detailed study of interaction of the modeled 
structure with human plasminogen, Mg++ ion was inserted 
under the energy constraint of amber [13] force field 
implemented in the program Chimera. 
 
Interaction of Salmonella enolase and Human Plasminogen 
Human plasminogen is about 810 amino acid residues long 
containing different conserved domains such as ligand binding 
sites, putative domain-interaction sites, active sites and 
cleavage sites. We selected plasminogen structures which have 
a maximum coverage of ligand binding sites. 1B2I (residue 
position 183-263) and 1DDJ (residue position 564-810) were 
considered for the plasminogen activation studies. Based on 
rigid-body docking using Grommacs server and VEGAZZ, 
conformational changes were analyzed in both proteins to 
study the activation of plasminogen to plasmin (Figure 1 A). 
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Figure 1: Salmonell and human enolase overlapping complex 
(A), docked regions being highlighted in circles in Human (B) 
and Salmonella (C) enolase respectively 
 
1B2I (Kringle 2 Domain of Human Plasminogen) 83aa 
Tissue-type plasminogen activator kringle-2 domain has two 
ligand binding sites one at C-terminal (lysyl residue), Tyr-Leu-
Leu-Lys (YLLK) and one at N-terminal, Ala-Phe-Gln-Tyr-His-
Ser-Lys (AFQYHSK). The sequence AFQYHSK is found within 
the plasminogen activation peptide whereas tetrapeptide 
YLLK corresponds to fibrinogen-B beta chain. Ligand-free and 
ligand-bound kringle 2 samples leads to the conclusion that all 
the small ligands as well as the C-terminal interact with a 
common binding site in kringle-2. Aromatic rigs of Tyr36, 
Trp62, His64, Trp72, Tyr74 and aliphatic side chains of Val35 
and Asp55 participate in the common ligand binding sites of 
kringle-2 domain. Interaction between refined 1B2I Structure 
of Human Plasminogen with the modeled structure on 
common ligand binding sites shows conformational change in 
reported binding sites and different representation showing 
interaction of Plasminogen binding sites with Modeled 
Structure with conformational changes (Figure 2)[14, 15, 16]. 
 
 
Figure 2: Plasminogen-enolase interaction with 1B2I (A) and 1DDJ (B) domains respectively 
 
1DDJ (crystal structure of human plasminogen catalytic 
domain) 247aa: 
In this Structure N domain, consist of an activation loop (550-
570aa), Ca binding loop (620-630aa), autolysis loop (670-690aa), 
methonine loop(710-729aa), oxyanion stabilizing loop(730-
760aa), with two, six and seven-stranded beta-barrel. Each 
Beta-barrel forms the core of another separate subdomain. The 
N domain and C domain are connected by three trans- 
segments as well as the A-chain peptide (residues 542-557). 
The molecular surface of mPLG (micro plasminogen) consists 
of various loops and two Alpha-helices. Functionally active 
loop (558-566) is involved in plasminogen activation by tissue 
type plasminogen activator (tPA) and urokinase [17]. 
 
Interaction between four chains of 1DDJ with Modeled 
Structure and interaction with different representations of the 
activation loop in chain `B` confirms the direct interaction of 
modeled enolase in Plasminogen activation. Plasmin 
production and  
Proteolysis in order to penetrate the host extracellular matrix 
by Salmonella enolase involves plasminogen activation which 
can be observed by conformational changes in the activation 
loop site. The proteolytic target bonds of Plasminogen (Arg 
561-Val 562) are completely accessible to the solvent. Upon 
activation the proteolysis- released alpha- amide group of 
Val562 moves in order to enter the activation pocket (Figure. 
2).  
 
Molecular Docking 
Enolase inhibitors were downloaded from PubChem as TSP 
(D-tartronate semialdehyde phosphate) and AEP (3-
aminoenolpyruvate phosphate). These were docked with 
human enolase and salmonella enolase on the basis of best 
binding score and ligand stable conformation. We hypothesize 
that both structures have a different expression scenario with 
different electrostatic potential on structure surface (Figure 1 B 
& C). 
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Conclusion: 
In the present study, it has been concluded that α-enolase 
could mediate the binding of S. Typhi to laminin, a major 
component of the basal membrane of the vasculature. It can 
therefore be postulated that the plasminogen–enolase 
association may play a critical role in the virulence of S. Typhi 
by causing direct damage to the host cell extracellular matrix, 
possibly by enzymic degradation of extracellular matrix 
proteins or other protein constituents. This might function as a 
guidance mechanism, first allowing S. Typhi adherence to the 
extracellular matrix, initiating tissue colonization, followed by 
plasminogen activation and laminin degradation in restricted 
areas. Hence, expression of α-enolase at the cell surface seems 
to be a common mechanism by which S. Typhi could induce 
destruction of the extracellular matrix, hence favoring their 
invasion and dissemination. Attempts to block this interaction 
could be of clinical relevance. Structural differences between 
enolase salmonella and human can provide a better 
understanding of bacterial survival inside host. Specifically, 
the bacterial metabolic enzyme could prove to be a potential 
drug target or could increase the efficiency of exiting drugs. 
Autoimmune responses need to be further answered with in 
vitro or in vivo validations. 
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